Compare GALT & INSW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GALT | INSW |
|---|---|---|
| Founded | 2000 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Semiconductors |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 199.2M | 2.8B |
| IPO Year | 2008 | 2016 |
| Metric | GALT | INSW |
|---|---|---|
| Price | $2.66 | $72.58 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 3 |
| Target Price | $8.50 | ★ $69.33 |
| AVG Volume (30 Days) | 336.8K | ★ 545.9K |
| Earning Date | 05-14-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 6.06% |
| EPS Growth | ★ 36.84 | N/A |
| EPS | N/A | ★ 6.23 |
| Revenue | N/A | ★ $843,302,000.00 |
| Revenue This Year | N/A | $9.52 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $11.60 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.15 | $27.20 |
| 52 Week High | $7.13 | $78.51 |
| Indicator | GALT | INSW |
|---|---|---|
| Relative Strength Index (RSI) | 42.65 | 56.31 |
| Support Level | $2.59 | $65.42 |
| Resistance Level | $3.27 | $73.61 |
| Average True Range (ATR) | 0.19 | 2.83 |
| MACD | -0.02 | -0.07 |
| Stochastic Oscillator | 18.37 | 83.53 |
Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis.
International Seaways Inc owns and operates a fleet of oceangoing vessels engaged in the transportation of crude oil and petroleum products. The company's vessel operations are organized into two segments: Crude Tankers and Product Carriers. The fleet consists of ULCC, VLCC, Suezmax, Aframax, and Panamax crude tankers, as well as LR1, LR2, and MR product carriers.